|Articles|August 1, 2013
- Applied Clinical Trials-08-01-2013
- Volume 22
- Issue 8
ACT Insert Cover
S
Advertisement
Cover
Articles in this issue
almost 13 years ago
Looking Further Into Transparencyalmost 13 years ago
The Practical Implementation of Risk-Based Monitoringalmost 13 years ago
Guidance and Strategies for Spurring Development of New Therapiesalmost 13 years ago
RBM in Late Phasealmost 13 years ago
Paperless Clinical Trial Optimization—Thinking Outside the Boxalmost 13 years ago
Controversy Grows Over How Best to Share Dataalmost 13 years ago
SOPs in Clinical Researchalmost 13 years ago
Comprehensive Evidence Development: Progress and Opportunitiesalmost 13 years ago
Risk-Based Approachesalmost 13 years ago
Impact on the FutureAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5